OMENN GILBERT S

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$735,658.64
Insider Sells Quantity
9
Insider Sells Sum
$4.57M

Insider Activity of OMENN GILBERT S

The largest purchase of all time was on 2020-09-29 and amounted to 40000 shares of Amesite Inc. for $200,000.

The largest sale of all time was on 2012-11-26 and amounted to 26000 shares of Amgen Inc. for $2.26M.

Biography of OMENN GILBERT S

No biography is available at this moment.

2021-12-14PurchaseAmesite Inc.
AMST
director
8,000
0.0031%
$1.17$9,354-53.09%
2021-12-13PurchaseAmesite Inc.
AMST
director
8,000
0.0032%
$1.18$9,471-52.17%
2020-09-29PurchaseAmesite Inc.
AMST
director
40,000
0.0224%
$5.00$200,000-8.89%
2019-05-31PurchaseGalectin Therapeutics Inc.
GALT
director
18,578
0.0392%
$4.28$79,514-23.33%
2018-09-10SaleGalectin Therapeutics Inc.
GALT
director
8,370
0.0216%
$6.00$50,220-18.84%
2018-09-07SaleGalectin Therapeutics Inc.
GALT
director
11,000
0.0272%
$6.03$66,365-22.57%
2017-03-21PurchaseEsperion Therapeutics, Inc.
ESPR
director
2,000
0.0096%
$42.26$84,520+24.97%
2016-03-01PurchaseEsperion Therapeutics, Inc.
ESPR
director
10,000
0.0437%
$15.28$152,800-16.29%
2014-10-21PurchaseEsperion Therapeutics, Inc.
ESPR
director
10,000
0.0536%
$20.00$200,000+170.46%
2012-11-26SaleAmgen Inc.
AMGN
director
26,000
0.0034%
$87.11$2.26M+20.75%
2008-12-08SaleAmgen Inc.
AMGN
director
16,000
0.0015%
$58.10$929,523-3.19%
2006-03-03SaleAmgen Inc.
AMGN
director
1,600
0.0001%
$76.78$122,850-7.88%
2006-03-01SaleAmgen Inc.
AMGN
director
1,600
0.0001%
$76.17$121,877-8.63%
2006-02-22SaleAmgen Inc.
AMGN
director
6,000
0.0005%
$75.22$451,312-7.21%
2005-03-07SaleAmgen Inc.
AMGN
director
2,000
0.0002%
$62.55$125,090+21.39%
2005-02-11SaleAmgen Inc.
AMGN
director
7,000
0.0006%
$63.24$442,650+18.16%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.